Metropolis Healthcare Limited (NSE:METROPOLIS)
India flag India · Delayed Price · Currency is INR
575.00
+6.30 (1.11%)
Nov 4, 2026, 3:30 PM IST

Metropolis Healthcare Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
17,82816,45813,31212,07711,48212,283
Revenue Growth
20.19%23.64%10.22%5.18%-6.52%23.08%
Cost of Revenue
3,8673,7263,0302,6992,7412,976
Gross Profit
13,96112,73210,2829,3788,7429,307
Selling, General & Admin
5,9945,7434,7984,1383,7303,649
Research & Development
279.73230.05102135.7765.7169.07
Other Operating Expenses
3,1482,7442,3522,2092,0172,140
Operating Expenses
10,78010,0548,3397,4276,7046,491
Operating Income
3,1802,6781,9431,9512,0372,817
Interest Expense
-268.3-245.44-185.75-225.36-268.01-197.42
Interest & Investment Income
38.1238.1256.6769.1102.3111.48
Currency Exchange Gain (Loss)
67.8567.85--59.57-1.84-6.11
Other Non Operating Income (Expenses)
109.5109.511.81--048.02
EBT Excluding Unusual Items
3,1282,6481,8161,7351,8702,773
Impairment of Goodwill
------1.88
Gain (Loss) on Sale of Investments
33.8433.8475.0611.566.784.26
Gain (Loss) on Sale of Assets
-6.83-6.8317.59-0.08-0.16
Asset Writedown
-----1.35-0.34
Other Unusual Items
-83.41-83.41---159.02
Pretax Income
3,0712,5921,9091,7471,8752,934
Income Tax Expense
817679.94453.39462.33441.09786.65
Earnings From Continuing Operations
2,2541,9121,4551,2851,4342,147
Minority Interest in Earnings
-11.19-11.65-5.46-6.39-5.11-5.04
Net Income
2,2431,9001,4501,2781,4292,142
Net Income to Common
2,2431,9001,4501,2781,4292,142
Net Income Growth
41.75%31.08%13.42%-10.54%-33.29%16.98%
Shares Outstanding (Basic)
207207207205205205
Shares Outstanding (Diluted)
207207207206205206
Shares Change
0.03%-0.12%0.69%0.05%-0.09%0.49%
EPS (Basic)
10.849.197.016.246.9810.47
EPS (Diluted)
10.839.197.006.226.9510.41
EPS Growth
41.71%31.29%12.58%-10.57%-33.25%16.40%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
4,1023,0722,1932,0031,9452,226
Free Cash Flow Per Share
19.8114.8610.609.749.4610.82
Dividend Per Share
1.0002.000-1.0002.0002.000
Dividend Growth
----50.00%0%0%
Gross Margin
78.31%77.36%77.24%77.65%76.13%75.77%
Operating Margin
17.84%16.27%14.60%16.16%17.74%22.93%
Profit Margin
12.58%11.54%10.89%10.58%12.44%17.44%
Free Cash Flow Margin
23.01%18.67%16.48%16.59%16.94%18.12%
EBITDA
3,4972,9732,1472,1762,3563,067
EBITDA Margin
19.61%18.06%16.13%18.02%20.52%24.97%
D&A For EBITDA
316.5294.53204.24224.79318.6250.63
EBIT
3,1802,6781,9431,9512,0372,817
EBIT Margin
17.84%16.27%14.60%16.16%17.74%22.93%
Effective Tax Rate
26.60%26.24%23.76%26.47%23.52%26.82%
Revenue as Reported
18,08416,71413,46312,16811,63412,460
Advertising Expenses
-441.29379.48327.74261.56260.32